CA ACR92

Designates October 23, 2022, as Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Awareness Day in California

Defines AADC deficiency as a rare, life-limiting genetic neurologic condition affecting approximately one in 100,000 people in the United States that prevents patients from developing motor skills, cognitive abilities, and language skills due to lack of the AADC enzyme needed to create dopamine

Identifies key symptoms of AADC deficiency including unexplained low muscle tone, developmental delays, and involuntary eye movements, diagnosed through genetic and biochemical tests

Notes that an AADC deficiency clinical trial is scheduled at Lucile Packard Children's Hospital Stanford, concluding by July 15, 2023

Encourages Californians to become better informed about AADC deficiency in public and medical communities